Barclays Maintains Underweight on Molina Healthcare, Raises Price Target to $161

Benzinga Newsdesk www.benzinga.com Positive 85.8%

Neg 0% Neu 0% Pos 85.8%

Barclays analyst Andrew Mok maintains Molina Healthcare (NYSE:MOH) with a Underweight and raises the price target from $133 to $161.